InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Aslan Fred. Insider active across 1 company, notably Artiva Biotherapeutics, Inc.. Aggregated, 11 filings have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €962k. History available since 22 July 2024. The latest transaction was filed on 10 September 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Aslan Fred is a declarant linked to Artiva Biotherapeutics, Inc., where the listed role is President and CEO. Across 8 filings in total, the 8 sampled filings from 2024-07-22 to 2026-02-18 show EUR 0 of buys and EUR 147065 of sells, with the modal transaction nature listed as Attribution.